Cargando…
Specialized Information Processing Deficits and Distinct Metabolomic Profiles Following TM-Domain Disruption of Nrg1
Although there is considerable genetic and pathologic evidence for an association between neuregulin 1 (NRG1) dysregulation and schizophrenia, the underlying molecular and cellular mechanisms remain unclear. Mutant mice containing disruption of the transmembrane (TM) domain of the NRG1 gene constitu...
Autores principales: | O’Tuathaigh, Colm M. P, Mathur, Naina, O’Callaghan, Matthew J, MacIntyre, Lynsey, Harvey, Richard, Lai, Donna, Waddington, John L, Pickard, Benjamin S, Watson, David G, Moran, Paula M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581893/ https://www.ncbi.nlm.nih.gov/pubmed/28338897 http://dx.doi.org/10.1093/schbul/sbw189 |
Ejemplares similares
-
Potentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2)-deficient mice: Do antipsychotics influence learning to ignore irrelevant stimuli via both Drd-2 and non-Drd-2 mechanisms?
por: O’Callaghan, Matthew J, et al.
Publicado: (2014) -
Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond
por: Waddington, John L., et al.
Publicado: (2020) -
Investigation of the relationship between patient empowerment and glycaemic control in patients with type 2 diabetes: a cross-sectional analysis
por: Fitzgerald, Maire, et al.
Publicado: (2015) -
Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models
por: Moran, Paula, et al.
Publicado: (2016) -
𝒟-Amphetamine and Antipsychotic Drug Effects on Latent Inhibition in Mice Lacking Dopamine D(2) Receptors
por: Bay-Richter, C, et al.
Publicado: (2013)